News

Ms Eastham has been elected to serve as a class I director of Genoptix until the 2011 annual meeting of stockholders and will also serve on the audit

The data indicated that a single in vivo administration of MDRNA meroduplexes targeting apolipoprotein B mRNA formulated in a DiLA2 delivery vehicle showed robust activity in a mouse

The FDA approval of Diovan HCT and Exforge for first-line use reinforces current US guideline recommendations to start appropriate patients on combination therapy. With the approvals, healthcare professionals

Under the terms of the agreement, Gilead will assume the lead role in the registration, manufacturing and distribution of Atripla in Argentina, Australia, Chile, Hong Kong, Israel, Mexico,

Mr Hutchins will be responsible for leading the company’s global business development and reinforcing WuXi’s brand value and market leadership. Mr Hutchins will report directly to Ge Li,

The company sold 6.68 million units to certain current and new institutional shareholders and certain affiliates of the company. Each unit was comprised of one share of common

The transaction consists of $3.5 million in cash and $1.5 million in Global Med common stock. eDonor is a web-based donor relationship management system that integrates recruitment, scheduling,

Schering-Plough has acquired sugammadex in November 2007 through its acquisition of Organon BioSciences, which developed the product. Thomas Koestler, executive vice president and president of Schering-Plough Research Institute,

The Cardene I.V. 200ml ready-to-use (RTU) bags contain 20mg of the anti-hypertensive agent nicardipine hydrochloride (0.1mg/ml) in either dextrose or sodium chloride. EKR further noted that it will